Clinical Trial: A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07083401) titled 'A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)' on July 16.

Brief Summary: This was an open-label, randomized, fed, single-dose, 2-sequence, 2- period crossover study to evaluate the pharmacokinetics and safety between single oral administration of "BR3006" and co-administration of "BR3006A", "BR3006B," and "BR3006C" in healthy adult volunteers.

Study Start Date: July 05

Study Type: INTERVENTIONAL

Condition: Diabete Mellitus

Intervention: DRUG: Dapagliflozin 10 mg/Pioglitazone 30 mg/Metformin HCl 1000 mg

Orally...